The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable anticipation within the market. A shift away from Schedule I status, often considered as outdated and hindering https://shaniajgya626918.hyperionwiki.com/1897248/cannabinoid_rescheduling_a_growth_catalyst